AGENT DE TRAITEMENT DES TROUBLES COGNITIFS, BASÉ SUR LA PROTÉINE BÊTA-AMYLOÏDE, AGENT THÉRAPEUTIQUE CONTRE LA MALADIE D'ALZHEIMER ET PROCÉDÉ DE TRAITEMENT ET PROCÉDÉ D'ANALYSE PATHOLOGIQUE CORRESPONDANTS
National University Corporation Okayama University;National University Corporation Hokkaido University
发明人:
申请号：
EP14785535.7
公开号：
EP2987496B1
申请日:
2014.04.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention aims to provide an anti-Alzheimer's disease agent based on an action mechanism associated with amyloid ² protein, which action mechanism is different from conventional action mechanisms. The therapeutic drug for Alzheimer's disease according to the present invention contains a therapeutic agent for cognitive impairment induced by amyloid ² protein, which therapeutic agent comprises a peptide having the amino acid sequence represented by SEQ ID NO:1 or a peptide similar to this peptide, especially a peptide containing the amino acid sequence represented by SEQ ID NO:2, which is a partial sequence of SEQ ID NO:1. VLSSQQFLHRGHQPPPEMAGHSLASSHRNSMIPSAAT (SEQ ID NO:1) HRGHQPPPEMA (SEQ ID NO:2)
